Thrombosis is the second most common preventable cause of death in patients with cancer, so oncologists need to know how to identify who is at risk, and strategies for prevention and treatment. This overview presents the evidence and raises alerts about the use of oral anticoagulants in the cancer setting.
The complexity of cancer, the risks and benefits associated with alternative treatment options, the care needs of patients, all point to the need for input from specialists in many disciplines. But are regular face-to-face multidisciplinary team meetings the best way to achieve this?
Better understanding of the impact that treating pregnant women for cancer has on their unborn child means women in this position have more options open to them, as Ainhoa Iriberri explains in this article, which was first published in SALUDRevista Â– a leading Spanish health magazine Â– and won her a Best Cancer Reporter runner-up award.